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ABSTRACT  
 
In many γ-proteobacteria, the RpoS/σS sigma factor associates with the core RNA polymerase 
(RNAP) to modify global gene transcription in stationary phase and under stress conditions. 
The small regulatory protein Crl stimulates the association of σS with the core RNAP in 
Escherichia coli and Salmonella enterica serovar Typhimurium (S. Typhimurium), through 
direct and specific interaction with σS. The structural determinants of Crl involved in σS 
binding are unknown. Here, we report the X-ray crystal structure of the Proteus mirabilis Crl 
protein (CrlPM) and a structural model for S. Typhimurium Crl (CrlSTM). Using a combination 
of in vivo and in vitro assays, we demonstrated that CrlSTM and CrlPM are structurally similar 
and perform the same biological function. In the Crl structure, a cavity enclosed by flexible 
arms contains two patches of conserved and exposed residues required for σS binding. Among 
these, charged residues likely to be involved in electrostatic interactions driving Crl-σS 
complex formation were identified. CrlSTM and CrlPM interact with domain 2 of σS with the 
same binding properties as with full-length σS. These results suggest that Crl family members 
share a common mechanism of σS binding in which the flexible arms of Crl might play a 
dynamic role. 
 
SUMMARY STATEMENT 
 
The Crl protein binds and activates the σS subunit of bacterial RNA polymerase. In vivo and 
in vitro studies revealed that the σS binding determinants of Crl lie in conserved residues 
located in a cavity enclosed by flexible arms. 
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INTRODUCTION 
 
Transcription in bacteria is carried out by a multi-subunit RNA polymerase (RNAP) 
[1]. When the catalytically active core RNAP (α2ββ’ω, E) associates with one of several σ 
factors, the RNAP holoenzyme (Eσ) is directed towards a specific set of promoters, 
depending on the sigma factor bound [2, 3]. Sigma factors present in cells compete for 
binding to a limited amount of E [4, 5]. The housekeeping sigma factor, σ70, is the most 
abundant throughout the growth cycle, and exhibits the highest affinity of all sigma factors for 
E in vitro [4, 5]. At the onset of the stationary phase or in response to specific stress 
conditions, σS (also called σ38 or RpoS) starts to accumulate, transcribing genes essential for 
the general stress response and for stationary phase survival [2, 4-7]. The low concentration 
and affinity for E of σS with respect to σ70 represent limiting steps in the competition of σS for 
E binding, and thus, in the expression of rpoS-dependent genes [5-7]. Bacteria use different 
strategies to overcome this obstacle by resorting to regulatory factors such as Rsd, 6S RNA 
and ppGpp [5]. All these factors act at the expense of Eσ70, thus promoting the formation of 
alternative holoenzymes such as EσS. Another important regulator that increases σS 
competitiveness is the small protein Crl [8-14]. Contrary to the above mentioned regulators 
and classical transcriptional factors that bind to DNA, Crl binds directly to σS facilitating EσS 
formation [9, 13-15]. Kinetic studies have shown that Crl binding to σS increases the 
association rate of σS with core RNAP and that the σS-Crl complex has a short half-life (about 
3 s) [15]. It has been proposed that Crl may help σS to adopt a conformation with higher 
affinity for E. 
 Previous studies demonstrated that Crl does not interact with σ70 and functions as a σS-
specific RNAP holoenzyme assembly factor [13-15]. However, Crl is not as widespread as σS 
in bacteria, and there are many rpoS-containing species that do not possess a crl gene [16]. 
Furthermore, in bacterial species containing both crl and rpoS, Crl is less conserved at the 
sequence level than σS (percentage of sequence identity ranging from 35 to 90 for Crl and 72 
to 100 for σS) [16]. It is therefore questionable whether Crl has the same σS activation role in 
all species that contain a crl gene. So far, Crl has only been functionally characterized in two 
closely related bacteria, Escherichia coli and Salmonella enterica serovar Typhimurium (S. 
Typhimurium) and has the same σS-enhancer action in both species [8-15], which is not 
surprising given the high level of sequence identity between these two heterologous Crl 
proteins (84 %).  
 σS belongs to the σ70-family of sigma factors [17-19] whose members contain at least 
two structural domains connected by flexible linkers: domain 2, which binds the promoter –10 
element, and domain 4 which binds the –35 element of the promoter. Previous studies have 
focused on the binding region of σS involved in the interaction with Crl. Indeed, using a 
bacterial two-hybrid system (BACTH), we demonstrated that the fragment encompassing 
residues 72 to 167 of σS domain 2 is the only region involved in the specific interaction with 
Crl from Salmonella [20]. At the sequence level, domain 2 is the most highly conserved 
domain in the σ70-family [17-19]. A recent work pointed to some residues in σS domain 2 that 
are necessary and sufficient for Crl from E. coli to discriminate between σ factors other than 
σS [14]. Regarding Crl, we previously reported that four conserved residues are important for 
its activity and for σS-Crl interaction [16]. However, a Crl three-dimensional structure was not 
available and this made difficult to understand if the identified residues belong to the same 
region in the structure and if they are exposed and available for interaction with σS. Recently, 
the crystal structure of Crl from Proteus mirabilis (CrlPM) was released in the Protein data 
Bank (PDB 3RPJ, unpublished), providing an important contribution to the comprehension of 
the Crl structure-function relationships. However, CrlPM has not been functionally 
characterized and Crl from P. mirabilis and from S. Typhimurium (CrlSTM) share only 47 % 
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sequence identity, which might result in local structural differences important for their 
biological function. 
 Many issues remain to be addressed concerning the Crl-σS partnership and its 
biological function, among which: whether Crl proteins have the same σS-activator function 
and σS binding region in various bacterial species, what is the region of Crl involved in the 
direct interaction with σS and what are the determinants that drive the σS-Crl complex 
formation and its fast dissociation rate. To gain insight into the above questions, we solved 
the crystal structure of CrlPM, modeled the structure of CrlSTM, and performed functional 
analyses of both proteins in vitro and in vivo. Our data demonstrated that CrlSTM and CrlPM 
display similar structural properties in solution and the same σS-enhancer activity, suggesting 
a common functionality in Crl family members. We further studied the interaction of CrlSTM 
and CrlPM with σSSTM and its domain 2 alone, showing that σS domain 2 possesses the same 
binding parameters as full-length σS and that no other domains take part in the transient 
formation of the σS-Crl complex. Finally, combined analyses of the CrlPM X-ray crystal 
structure obtained in this study and the effects of crl mutations in in vivo and in vitro assays, 
located a cavity enclosed by flexible loops in the Crl structure, in which conserved and 
exposed residues important for the interaction with σS were identified.  
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MATERIAL AND METHODS 
 
Bacterial strains, bacteriophage, plasmids and growth conditions 
 
Strains and plasmids used in this study are listed in Supplementary Table S1. Bacteriophage 
P22HT105/1int was used to transfer mutations between Salmonella strains by transduction 
[21]. Green plates, for screening for P22-infected cells or lysogens, were prepared as 
described previously [22]. Strains were routinely grown in Luria-Bertani (LB) medium [23] at 
37°C under aeration. Development of the rdar morphotypes was observed on CR plates (LB 
agar without NaCl supplemented with Congo red 40 μg/ml and Coomassie brilliant blue R250 
20 μg/ml), at 28°C as described [11]. Antibiotics were used at the following concentrations: 
ampicillin (Ap) 100 μg/mL; carbenicillin (Cb) 100 μg/mL; chloramphenicol (Cm) 15 μg/mL 
for the chromosomal resistance gene and 30 μg/mL for the plasmid resistance gene; 
kanamycin (Km) 50 μg/mL; and tetracycline (Tet) 20 μg/mL.  
 
crl allelic exchange in Salmonella 
 
Allelic exchange of crl in S. Typhimurium ATCC14028 was achieved with a two-step Red-
recombinase-based recombineering procedure [24-26]. The procedure involves 1) 
replacement of the crl coding sequence by a tetRA module (produced by PCR, Table S2) 
yielding strain VFD416, and 2) replacement of the tetRA module by a PCR-amplified DNA 
fragment (Table S2) of the crl allele from pVFB430, pVFD49 and VFC362 through positive 
selection of tetracycline-sensitive recombinants. All strains were confirmed to contain the 
expected mutation by DNA sequencing.  
 
BACTH analyses 
 
The bacterial adenylate cyclase-based two hybrid (BACTH) assay is dependent upon the 
functional reconstitution of the Bordetella pertussis adenylyl cyclase T18 and T25 sub-
domains by two interacting partners [27]. The resulting cyclic AMP binds to and activates the 
transcription activator CRP, a positive regulator of the lac and mal operons involved in 
lactose and maltose catabolism. The E. coli cya strain DHT1 was transformed with 
derivatives of plasmids pKT25 and pUT18 encoding σS and Crl proteins fused to the C-
terminal part of T25 and the N-terminal part of T18, respectively. Co-transformants were 
plated onto MacConkey maltose plates supplemented with carbenicillin, kanamycin, and 0.5 
mM IPTG to assess the Mal phenotype and on LB plates supplemented with X-Gal (40 
μg/ml) Cb, Km, and IPTG (0.5 mM) to assess the Lac phenotype. Plates were incubated at 
30°C for 2 days and then isolated colonies were grown in LB supplemented with Cb, Km, and 
IPTG, at 30°C for 20 hours. β-galactosidase activities were measured as described by Miller 
[28].  
 
ITC and SPR experiments  
 
ITC experiments were carried out at 25°C using a MicroCal VP-ITC microcalorimeter (GE 
Healthcare) with a cell volume of 1.5 mL. In each titration experiment, volumes of 7-10 µL of 
a solution containing CrlSTM or CrlPM at concentrations of 200-230 µM were injected into a σS-
containing solution in the same buffer (50 mM Na-phosphate pH 8.0, 300 mM potassium 
glutamate), using a computer-controlled 250 µL microsyringe. All the σS samples were 
prepared at concentrations of 15-20 µM. SPR binding assays were conducted on a Biacore 
X100 instrument (GE Healthcare), equilibrated at 25°C in 50 mM Na-phosphate pH 8.0, 300 
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mM potassium glutamate as previously described [15]. All experiments were performed in 
triplicate and standard deviations were calculated. For details see Supplementary Material and 
Methods. 
 
Crystallization and structure determination of recombinant Crl and homology modeling 
 
Initial screening of crystallization conditions was carried out for CrlSTM and CrlPM by the 
vapour diffusion method with a MosquitoTM nanoliter-dispensing system (TTP Labtech). 
Sitting drops were set up using 400 nL of a 1:1 mixture of each Crl protein and crystallization 
solutions (672 different commercially available conditions) equilibrated against 150 µL 
reservoir in multiwell plates (Greiner Bio-One). The crystallization plates were stored at 18°C 
in a RockImager1000TM (Formulatrix) automated imaging system to monitor crystal growth. 
Only CrlPM yielded suitable crystals. Manual optimization was performed in Limbro plates by 
the hanging-drop method. The best crystals were obtained by mixing 1.5 µL of protein at 16.3 
mg/mL with 1.5 µL reservoir solution containing 30 % (w/v) PEG3000 and 100 mM CHES-
NaOH pH 9.5. Single crystals were flash-cooled in liquid nitrogen using a mixture of 50% 
Paratone-N and 50% paraffin oil as cryoprotectant. X-ray diffraction data were collected on 
beamline PROXIMA-1 at Synchrotron SOLEIL (Saint-Aubin, France). The diffraction 
images were integrated with the program XDS [29] and crystallographic calculations were 
carried out with programs from the CCP4 program suite [30]. The structure of CrlPM was 
solved by the molecular replacement method with the program Phaser [31] using PDB entry 
3RPJ as a template. Two independent protein molecules were identified in the 
crystallographic asymmetric unit. The structures were refined by alternate cycles of restrained 
maximum-likelihood refinement with the program Refmac5 [32] and manual adjustments 
were made to the models with Coot [33]. TLS refinement was used in the last cycles of 
refinement, with one TLS group per molecule.   
The structure of CrlSTM was modeled using the crystal CrlPM structure (chain A of 4Q11) as a 
template, with the program MODELLER provided by the Bioinformatics Toolkit 
(http://toolkit.tuebingen.mpg.de/modeller) [34]. The model quality was assessed using the 
ModFOLD server [35]. The CrlSTM model has a global model quality score of 87 % and a P-
value 1.07*10-4. The model spans residues 1 to 133. Structural superpositions were performed 
using the TM-align server [36]. This model was also validated by a theoretical calculation of 
the hydrodynamic properties of the crystal structure of CrlPM (4Q11) and the structural model 
of CrlSTM. All structural figures were generated with PyMOL (http://www.pymol.org). 
 
Methods for DNA manipulation and immunoblot analysis of proteins, protein 
production and purification and DSC, CD, fluorescence and AUC experiments are 
described in Supplementary Material and Methods.  
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RESULTS AND DISCUSSION 
 
Structural features of Crl  
 
 Crl has been reported to bind σS and increase its activity in two closely related species, 
S. Typhimurium and E. coli K12 [8-16], but three-dimensional structures for these Crl 
proteins are not available. The crystal structure of Crl from P. mirabilis was solved by the 
Midwest Center for Structural Genomics consortium (pdb entry 3RPJ; unpublished work), but 
this protein has not been functionally characterized. Both P. mirabilis and S. Typhimurium 
belong to Enterobacteria but their Crl proteins share 47 % sequence identity (Supplementary 
Figure S1A), which is lower than the 79 % sequence identity shared by their σS proteins 
(Supplementary Figure S1B). 
 Our attempts to crystallize CrlSTM were unsuccessful despite numerous trials under 
different screening conditions, including seeding with crystals of CrlPM. On the contrary, we 
obtained crystals of CrlPM under different crystallization conditions and with a different space 
group (P21) than the 3RPJ crystal structure (P212121), and we solved the corresponding 
structure at 1.95 Å resolution (PDB code 4Q11). The crystal parameters, data statistics, and 
final refinement parameters are shown in Supplementary Table S3. Two independent 
monomers are present in the asymmetric unit (Figure 1A). Continuous electron density was 
seen for residues 7-132 in monomer A and 5-130 in monomer B. The two monomers were 
superimposed with an rmsd of 0.36 Å for 123 equivalent Cα atoms. Each monomer folds as a 
single α/β domain containing four α-helices (α2 and α4 are 310 helices), a five-stranded 
mixed β-sheet and an additional single β-strand with an overall α1α2β1β2β3β4β5α3β6α4 
architecture (Figure 1B and Supplementary Figure S1A). In the crystal structure, two types of 
dimers were observed with interfaces of 685 and 987 Å2, respectively [37]. The first dimer is 
formed by the two independent monomers (A, B) related by a non-crystallographic two-fold 
axis between the β5 strands (Figure 1A) and is conserved in the 3RPJ structure. The second 
dimer (Supplementary Figure S2) is formed by monomer A and a symmetry-equivalent 
monomer B. Superposition of the two dimeric structures gave rise to an rmsd of 0.42 Å for all 
equivalent Cα atoms). 
 Interestingly, the CrlPM structure contains an exposed cavity of approximately 16 Å in 
length and 8 Å deep enclosed by three flexible loops (loop 1 including residues 22-32, loop 2 
including residues 42-52, loop 3 including residues 77-80), and the bottom of the cavity is 
formed by the β1β2β3 antiparallel β-sheet (Figure 1B). High atomic temperature factor 
values were observed for loops 1 and 2, suggesting flexibility in these regions (the loop 3 
appeared to be less flexible) (Figure 1C). These loops may play a dynamic role in the 
biological activity of Crl. 
 
CrlPM and CrlSTM are monomeric proteins and share similar structural properties in 
solution 
 
 Previous studies using gel filtration analyses [9, 13] suggested that Crl is monomeric 
in solution. However, since two possible types of CrlPM dimers were observed in the 4Q11 
crystal structure and the dimeric form shown in Figure 1A is conserved in the 3RPJ and 4Q11 
structures, we explored the possibility of Crl dimer formation in solution. For this purpose, we 
performed AUC experiments with CrlSTM and CrlPM at different concentrations. Both proteins 
sedimented as single species compatible with a monomeric form at all the concentrations 
tested (Supplementary Figure S3). This finding is consistent with in silico analyses of the 
oligomerization state using PISA [37] suggesting that the dimers observed in the crystal 
structures of CrlPM are not stable. 
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We used additional biophysical techniques to further investigate whether CrlSTM and 
CrlPM adopt similar structures in solution. Far-UV and near-UV CD spectra showed a similar 
secondary and tertiary content for both Crl proteins (Supplementary Figure S4A,B). 
Analogously, fluorescence experiments revealed a similar structural arrangement around the 
tryptophans for both Crl proteins (Supplementary Figure S4C). Interestingly, the maximum of 
the fluorescence emission for CrlPM presents a blue-shift for both 280 nm and 295 nm 
excitation, suggesting a more closed structure for CrlPM with respect to CrlSTM. DSC 
experiments were performed to evaluate and compare the thermal stabilities of CrlSTM and 
CrlPM. The DSC thermogram of both Crl proteins displayed a single transition peak 
(Supplementary Figure S4D) and the thermal denaturation was irreversible (data not shown). 
The transition temperature for CrlSTM was higher than for CrlPM, indicating a higher thermal 
stability of CrlSTM with respect to CrlPM. In contrast, the enthalpy change correlated with the 
thermal unfolding of CrlPM is higher than CrlSTM, suggesting a different arrangement of intra-
molecular interactions that stabilize the secondary and tertiary structure of both proteins.  
Altogether, these results showed that CrlSTM and CrlPM globally adopt a similar 
secondary and tertiary structure in solution. The small spectral and thermal stability 
differences observed between the two proteins could result from local structural changes, 
notably in the flexible loops 1 and 2 and might potentially result in different binding 
mechanisms and affinities for σS. 
 
CrlPM interacts with σS and increases its activity in vivo 
 
We previously reported the function of Crl and its interaction with σS in S. 
Typhimurium [11, 12, 16, 20], but until now CrlPM had not been characterized. Since 
differences in the structure and/or sequence of CrlPM, compared to CrlSTM, may result in a 
different recognition mechanism of σS, we investigated whether CrlPM was able to bind σS 
using the BACTH system [27]. This assay is based on the functional reconstitution of 
adenylate cyclase activity using its T18 and T25 fragments and was successfully used to 
reveal the interaction between a C-terminal fusion of CrlSTM to the T18 fragment (CrlSTM-T18) 
of adenylate cyclase and an N-terminal fusion of  σSSTM to the T25 fragment (T25-σSSTM) of 
adenylate cyclase [16, 20]. The T25-σSSTM, T25-σSPM, CrlSTM-T18 and CrlPM-T18 proteins were 
used here to assess the efficiency of interactions between homologous and heterologous σS 
and Crl proteins (Figure 2A) and their expression levels were checked by immunodetection 
using T25 and T18 antibodies (Figure 2B). CrlPM was able to interact with σSPM. In addition, 
despite the low level of sequence identity of the couple CrlSTM-CrlPM with respect to σSSTM- 
σSPM, CrlPM and CrlSTM were able to bind σSSTM and σSPM, respectively. Whilst the T18 antibody 
was able to detect CrlSTM-T18 and CrlPM-T18 (Figure 2B), a polyclonal antibody directed 
against CrlSTM was efficient to recognize CrlSTM-T18 but not CrlPM-T18 (data not shown), 
suggesting that the major antigenic determinants located at the surface of CrlSTM are not 
conserved in CrlPM. 
 In a previous work, we characterized the σSSTM-CrlSTM interaction using surface 
plasmon resonance [15]. Sigma factors are flexible molecules [38] and dynamic 
conformational changes might be key features for their function and regulation. Therefore, to 
assess the possibility that the immobilization of (his)6-σS on the sensor chip might affect its 
binding properties for Crl, we monitored the σSSTM-CrlSTM and σSSTM-CrlPM interactions in 
solution by ITC experiments, using a σSSTM protein without a his-tag (Supplementary Figure 
S5). Analysis of the isotherms revealed that the stoichiometry of the σS-CrlSTM and σS-CrlPM 
complex was 1:1 with a KD value of 0.8 μM for CrlSTM and 0.4 μM for CrlPM (Table 1). It is 
worth noting that the affinity obtained for the interaction of σSSTM with CrlSTM was about three-
fold higher than that obtained by SPR ([15] and Figure 3A). Interestingly, the ΔbH values for 
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CrlSTM and CrlPM binding were similar (Table 1), suggesting that the driving forces for σS-Crl 
complex formation are similar for both Crl proteins. In particular, negative values of enthalpy 
changes imply that the binding between σS and Crl is likely driven by electrostatic interactions, 
whilst positive values of entropy changes suggest that hydrophobic contacts between the 
exposed apolar residues on the surface of both proteins might be involved.  
 The above results showed the ability of CrlPM to recognise and bind σS, in a similar 
manner as CrlSTM. To assess whether the interaction between σSSTM and CrlPM was functional, 
i.e. if CrlPM is able to increase σS activity in vivo, we performed allelic exchange in S. 
Typhimurium in which the crl gene was replaced by the crl allele from P. mirabilis. The 
ability of CrlPM to activate σSSTM was then evaluated by monitoring the development of the 
rdar morphotype by the recombinant S. Typhimurium strain (Figure 4A). Indeed, we 
previously reported that Crl is required for development of the rdar colony morphology of S. 
Typhimurium [11] caused by the σS-dependent production of curli and cellulose and 
correlated with biofilm formation [39]. In contrast to the Δcrl mutant of S. Typhimurium, 
strains harboring the crlPM allele displayed a typical rdar morphotype, indicating that CrlPM 
was able to increase the activity of σSSTM.  
 
Domain 2 of σS is sufficient for in vivo and in vitro interaction with Crl proteins 
 
  σS belongs to the σ70-family [17-19] whose members contain at least two structural 
domains connected by flexible linkers: σ2, which binds the promoter –10 element and σ4 
which binds the promoter –35 element (See Supplementary Figure S6A). Both domains also 
interact with the core RNAP [17-19]. We previously reported that residues 72 to 167 of σSSTM 
domain 2 are sufficient for CrlSTM-σSSTM interaction in BACTH assays [20]. Consistently, the 
Crl protein from E. coli was recently been shown to interact with domain 2 of σS [14]. As 
CrlPM has a two-fold higher affinity for σSSTM than CrlSTM (Table 1), it might recognize 
additional domains of σS. The truncated T25-σSSTM variants previously used in BACTH assays 
with CrlSTM [20], were used here with CrlPM (Supplementary Figure S6A). The only σSSTM 
fragments interacting with CrlPM were those containing domain 2. All the T25-σSSTM 
constructs had similar expression levels, when evaluated by immunodetection with the T25 
antibody (Supplementary Figure S6B). Therefore, residues 72 to 163 in σSSTM are sufficient 
for interaction in vivo with CrlPM, analogously as for CrlSTM [20]. 
So far, the only evidence that σS domain 2 interacts with Crl is based on experiments 
in bacterial two hybrid systems [14, 16, 20]. To characterize the in vitro interaction of σS 
domain 2 with Crl, a fragment of σSSTM, comprising residues from 53 to 162 (σS53-162), was 
purified using a co-expression system with CrlSTM (See Supplementary Materials and 
Methods). This co-expression strategy was adopted for two reasons: i) attempts to purify σS53-
162 alone failed as the protein was always found in the insoluble fraction (data not shown) and 
ii) because we could take advantage of the short life-time of σS-Crl complex to purify σS53-162 
without Crl. Indeed, to evaluate if σS53-162 was bound to CrlSTM or free in solution after 
purification, a small fraction of the purified protein was loaded onto a Superdex 75 10/300 GL 
column and then analyzed by immunodetection using His-tag antibody. The results 
demonstrated that σS53-162 was free in solution and the far-UV CD spectrum confirmed a 
correct folding of this domain (data not shown). However, at high concentrations, σS53-162 
aggregated and only a small percentage of the protein was in a monomeric form in AUC and 
DSC experiments (data not shown), which prevented us from performing ITC experiments. 
Therefore, SPR experiments were performed since low concentrations of (his)6-σS53-162  were 
sufficient to immobilize this protein on the sensor chip through its N-terminal end [15]. SPR 
experiments were also carried out between the full-length (his)6-σSSTM and CrlSTM, as a control 
(Figure 3). In these conditions, (his)6-σS53-162 was able to recognize and bind both CrlSTM and 
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CrlPM, confirming the in vivo data. CrlPM showed a two-fold higher affinity for σS53-162 than 
CrlSTM (KD,app = 3.0 ± 0.4 µM), in agreement with the results obtained for the full-length σS in 
ITC experiments (Supplementary Figure S5).  
Furthermore, the interaction of σS53-162 with CrlSTM gave a KD,app value of 7 ± 1 µM, 
very similar to that one obtained for the full-length σS (KD,app = 6.0 ± 0.7 µM). This finding 
showed for the first time that in vitro isolated σS domain 2 is sufficient to account for σS 
binding to Crl. Kinetic studies previously showed that σS-Crl is a transient complex with a fast 
dissociation phase [15]. The kinetics of interaction with CrlSTM of σS53-162 appeared to be 
similar to that of full-length σSSTM. These results suggested that domain 2 is the only domain 
of σS involved in both association and dissociation of the σS-Crl complex.  
 
Conserved residues in the Crl family members are mostly surface exposed 
 
 The results above showed that CrlPM and CrlSTM interact with domain 2 of σSSTM with 
similar binding parameters despite their lower sequence identity with respect to the couple 
σSSTM-σSPM. Thus, the interaction between σS and Crl might occur through either a specific Crl 
structural recognition motif or conserved residues on the surface of the protein. We previously 
identified 17 conserved residues in Crl-like proteins including CrlSTM and CrlPM 
(Supplementary Figure S1A) and alanine substitutions of some of these residues were shown 
to affect σS binding in BACTH and/or Crl activity in vivo [16]. To localise these residues in 
the Crl structure and understand the possible effects of mutations, we constructed the 
structural homology model of CrlSTM (Figure 5A) based on our X-ray crystal structure of CrlPM 
and on the alignment shown in Supplementary Figure S1A. This model was validated by a 
theoretical calculation of the hydrodynamic properties of the crystal structure of CrlPM (4Q11) 
and the structural model of CrlSTM.  
Interestingly, we observed that 80% of the identified conserved residues are surface 
exposed on the Crl structure. Of the 17 conserved residues, only four are buried inside the 
structure (Phe35, Gly55, Trp56, Gly74), and three of them were shown to be not required for 
σSSTM binding [16]. Indeed, the Ala variants of residues Phe35, Gly55 and Gly74 gave positive 
results in BACTH and/or in Crl activity assays. In contrast, the Crl Trp56Ala variant abolished 
σS binding and Crl activity [16]. Trp56 form an interaction network with neighbouring 
hydrophobic residues Tyr22, Tyr71 and Phe103 (Supplementary Figure S7A) and thus might be 
important for the overall structural stability of the protein. Therefore, in the following analysis, 
we focused on the other 13 Crl surface-exposed conserved residues and their possible 
implication in σS binding.  
 
Two patches of conserved and surface exposed residues in Crl are involved in σSSTM 
binding  
 
 Among these 13 residues, all except one (Glu52) are clustered in three different patches 
on the same face of the Crl structure (Figure 5B). Glu52 is located on the opposite face 
(Supplementary Figure S7B) and its substitution by alanine did not affect Crl activity and 
interaction with σS [16].  
 Patch 1 consists of residues Gly20, Pro21, Tyr22, Arg24 and Asp36. All residues, with the 
exception of Asp36, are located in loop 1 (Figure 5C). The Tyr22Ala substitution had a negative 
effect on σS binding in BACTH assays and, to a lesser extent, on CrlSTM activity in vivo [16]. 
The side chain of Tyr22 is oriented towards the long α2-helix and forms an interaction network 
with other conserved aromatic residues (Trp56 and Phe103), as mentioned above 
(Supplementary Figure S7A). The alanine substitution of residue Gly20 mildly affected the 
CrlSTM-σS interaction (Supplementary Figure S8). Residue Asp36 is located in the β2 strand 
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with its side chain oriented towards the center of the cavity and is a likely candidate for 
interaction with σS. Consistent with this hypothesis, the substitution Asp36Ala in Crl abolishes 
its interaction with σS (Figure 4B). Interestingly, residues Asp36 and Arg24 establish a salt 
bridge in the 4Q11 crystal structure, but Arg24 is unlikely to be directly involved in σS binding 
since the substitution Arg24Ala only slightly affected the CrlSTM-σS interaction (Figure 4B). 
Furthermore, the CrlSTM Arg24Ala-Asp36Ala variant did not interact with σS (Figure 4B), 
excluding the possibility that Asp36 is required solely to establish electrostatic interaction with 
Arg24. CrlSTM-T18 variants with alanine substitutions had similar expression levels with 
respect to wild-type CrlSTM-T18 (Figure 4D). Altogether these results suggested that Asp36 is a 
key residue for Crl-σS complex formation. 
Patch 2 (Cys41, Pro48, Arg51 and Phe53) faces patch 1 (Figure 5D) and all residues, 
except Phe53, are located in loop 2. Alanine substitution of Cys41 slightly affected the CrlSTM-
σS interaction (Supplementary Figure S8) and was active in vivo [16]. In contrast, the 
substitutions Arg51Ala and Phe53Ala drastically reduced the ability of Crl to interact with σS 
(Figure 4B and [16]). Residue Phe53 starts the β2-strand and might be important for the 
correct conformation of the protein. Arg51 is not involved in intra-molecular interactions and 
its side chain is oriented towards the outside of the molecule, making it a likely candidate for 
direct interaction with σS.  
Finally, three conserved residues (Trp57, Gly80, Trp82) form the hydrophobic patch 3 
(Figure 5E), in which Gly80 belongs to loop 3 and Trp57 and Trp82 are located in the β2 and 
β4-strands, respectively. The substitution Gly80Ala did not affect the σS-CrlSTM interaction and 
Crl activity [16], whereas substitutions Trp82Ala and Trp57Ala had mild effects on the activity 
of CrlSTM in vivo and its ability to bind σS in BACTH experiments [16]. Residues Trp57 and 
Trp82 make stacking contacts, likely contributing to the structural stability of Crl. Consistent 
with this finding, CrlSTM variants Trp82Ala and Trp57Ala showed a high propensity to 
aggregate in vitro (data not shown). Therefore, these residues might be involved in 
maintaining the overall conformation of Crl rather than directly interacting with σS.  
Altogether, these results pointed to conserved residues in Patch 1 and Patch 2 as 
potential candidates for direct interaction with σS and more specifically to the charged 
residues Asp36 and Arg51, consistent with ITC results suggesting that complex formation is 
driven by electrostatic interactions. The substitutions Arg51Ala and Asp36Ala strongly affected 
also the interaction between CrlPM and σSSTM, in agreement with data obtained for CrlSTM, 
whereas Arg24Ala had only a minor effect (Figure 4B). Furthermore, substitutions Asp36Ala 
and Arg51Ala abolished CrlSTM activity in vivo (Figure 4C,D). The lack of interaction of these 
CrlSTM variants with σSSTM was further confirmed in vitro by SPR and ITC experiments (Figure 
S9A). The absence of binding of these Crl variants to σS might be due to the substitution of 
key residues directly involved in electrostatic interactions with σS or to conformational 
effects. To discriminate between these two possibilities, a biophysical characterization of 
these variants was undertaken (Figure 6). CrlSTM Arg51Ala showed structural features similar 
to those of wild-type CrlSTM, and thus that the lack of interaction with σS is due to the 
substitution of a residue directly involved in σS binding. In the case of the CrlSTM Asp36Ala 
variant, it is more difficult to draw a definite conclusion since the Asp36Ala substitution 
decreases the secondary and tertiary structural content of the protein with respect to wild-type 
CrlSTM (Figure 6A,B). These results were in line with DSC thermograms (Figure 6C) that 
showed a lower transition enthalpy for the CrlSTM Asp36Ala variant, whilst CrlSTM Arg51Ala had 
a similar transition enthalpy to wild-type CrlSTM (ΔH = 35.0 ± 0.4 kcal mol-1).  It must be 
emphasized, however that even though the conformation of CrlSTM Asp36Ala was affected in 
vitro, the level of production of this variant was not affected in the S. Typhimurium strain in 
physiological conditions, indicating that the protein was not unstable (Figure 4D). Asp36 
establishes a salt bridge with Arg24 and makes hydrogen bonds with the side chain of Trp82 in 
	   12	  
patch 3. This interaction network between the bottom of the cavity, loop 1 and loop 3 could 
play a role in controlling the size of the cavity. The loss of these Asp36-mediated interactions 
could also explain the structural changes observed in the CrlSTM Asp36Ala variant (Figure 6). 
On the other hand, direct interaction between Asp36 and σS might affect the intra-molecular 
network involving Asp36 and this might, in turn, trigger a conformational change in Crl. 
Whether conformational changes in Crl occur upon σS binding and whether they affect the 
stability of the complex is an interesting issue for future studies. Additional experiments are 
underway to characterize in more detail the possible interaction networks involving Asp36, 
both within Crl and between Crl and σS. It is worth noting that albeit our study focussed on 
the role of conserved Crl residues involved in σS binding, non-conserved residues might affect 
the global affinity of Crl for σS. Indeed, the σS binding region of Crl corresponds to a cavity 
enclosed by flexible loops/arms. The non-conserved residues in the Crl loops might 
differentially modulate the flexibility of the arms, thus controlling the capacity of Crl from 
different species to interact with σS. This might result in the higher affinity of CrlPM observed 
for full-length σS and σS53-162 with respect to CrlSTM. Our future studies will focus on the 
functional role of the flexible loops in the Crl structure for the recognition and binding to σS 
and on the identification of the structural interface between Crl and domain 2 of σS. 
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CONCLUSION 
 
So far, Crl is the only known factor able to bind σS and increase its affinity for the core 
RNAP [11, 13-15]. Since σS is widespread in bacteria and well conserved at the sequence 
level, the narrow distribution of Crl among proteobacteria and its lower level of sequence 
conservation with respect to  σS might be surprising at first glance. Regulation of σS activity 
might have evolved in bacteria that do not contain crl to adapt to the specific lifestyle of 
bacteria and/or there might be functional homologues of Crl in these species. Our results with 
the Crl proteins from P. mirabilis (this study) and Vibrio cholerae (data not shown) suggest 
that Crl family members interact with σS and are functional. The overall tertiary structure of 
Crl is likely retained, with small differences that may result from local structural changes in 
the flexible loops present in the Crl structure. These loops may have dynamic roles in the 
recognition and binding mechanism of σS, as well as in the stability and/or regulation of Crl 
activity.  
Experiments using bacterial two-hybrid systems demonstrated that σS domain 2 
interacts with Crl proteins from S. Typhimurium [20], E. coli [14] and P. mirabilis (this 
study). In the present study, we further show that purified σS domain 2 (residues 52-162) 
accounts for the affinity and kinetics of interaction of full-length σS with CrlSTM and CrlPM. An 
interesting feature of the complex between Crl and either full-length σS or its domain 2 alone, 
is its short lifetime. This on-off mechanism is likely to be important in the process of σS 
activation and binding to the RNA polymerase, but its molecular basis is unknown. The 
flexibility of Crl might be a key feature, with Crl intrinsic dynamics controlling the 
association and dissociation steps. This dynamic behaviour may also be a key feature of the 
potential regulation of Crl activity by environmental signals, allowing bacteria to adjust Crl 
affinity for σS as needed. 
In this study, we identified in the Crl structure a cavity enclosed by flexible loops, 
containing surface-exposed residues important for the interaction with σS and conserved in 
Crl-family members. One of these residues, Arg51, is directly involved in the binding of σS, 
whereas Asp36 may establish a direct interaction with σS and/or contribute to conformational 
changes of Crl. A recent study in E. coli identified two areas in domain 2 of σS required for 
Crl binding [14]. This finding and the identification in this study of Crl structural patches and 
key residues involved in σS binding will facilitate the future delimitation of the Crl-σS 
interface.   
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TABLE LEGEND 
 
Table 1. Thermodynamic parameters of the interaction of σSSTM with both CrlPM and 
CrlSTM obtained by ITC at 25°C 
Each ITC experiment was performed in triplicate and standard deviations are reported.  
 
 n KD (μM) 
ΔbH 
(kJ/mol) 
TΔbS 
(kJ/mol) 
ΔbG 
(kJ/mol) 
σSSTM + CrlSTM 1.0 ± 0.1 0.8 ± 0.2 -8.2 ± 0.5 27 ± 1 -35 ± 1 
σSSTM + CrlPM 0.98 ± 0.07 0.4 ± 0.1 -5.9 ± 0.7 30 ± 1 -36 ± 1 
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FIGURE LEGENDS 
 
Figure 1. X-ray crystal structure of CrlPM (4Q11) 
(A) Cartoon representation of the CrlPM dimer with an interface of 987 Å2. The cavity formed 
by the β-strand bed and the flexible loops are indicated for one monomer of the asymmetric 
unit. (B) Single CrlPM monomer showing the α1α2β1β2β3β4β5α3β6α4 architecture and the 
three flexible loops. (C) B-factor representation of CrlPM. The loops 1 and 2 possess the 
highest temperature factor values. 
 
Figure 2. Interaction between Crl and σS proteins from S. Typhimurium and P. mirabilis 
in the BACTH assay 
(A) Interaction between the indicated hybrid proteins was quantified by measuring β-
galactosidase activity in E. coli DHT1 cells. Results are the mean of at least three independent 
experiments and standard deviations are indicated with black bars. (B) Immunodetection of 
T25-σS and Crl-T18 hybrid proteins using antibodies directed against T25 and T18, 
respectively. Lane 1: T25-unfused, lane 2: T25-σSSTM, lane 3: T25-σSPM, lane 4: unfused-T18, 
lane 5: CrlSTM-T18, lane 6: CrlPM-T18. 
 
Figure 3. SPR binding analysis of CrlSTM and CrlPM to full-length σSSTM and its domain 2 
(σS53-162).  
Association and dissociation real time profiles corresponding to the interaction of 
immobilised (his)6-σSSTM with CrlSTM (A) and of (his)6-σS53-162 with either CrlSTM (B) or CrlPM 
(C). The following Crl concentrations were used: 123 nM (black), 370 nM (pink), 1.1 μM 
(red), 3.3 μM (green), 10 μM (blue). In inset are shown the steady state response curves as a 
function of Crl protein concentration.  
 
Figure 4. Functional analyses of Crl variants in vivo  
Rdar morphotype of S. Typhimurium strains harboring the heterologous crlPM allele (A) and 
the crlSTM mutated alleles producing the Asp36Ala and Arg51Ala CrlSTM variants (C). The wild-
type strain ATCC14028 (WT) and its ΔrpoS and Δcrl derivatives were used as controls. (B) 
BACTH experiments with T25-σSSTM and the Crl-T18 hybrid proteins from S. Typhimurium 
and P. mirabilis carrying the indicated alanine substitutions. Interactions were quantified by 
measuring β-galactosidase activity. Results are the mean of at least three independent 
experiments and standard deviations are indicated with black bars. (D) Immunodetection of 
CrlSTM-T18 fusion proteins using antibody directed against T18 and of the CrlSTM variant 
proteins expressed in S. Typhimurium ATCC14028 (panel C) using an anti-CrlSTM antibody. 
 
Figure 5. Structural homology model of CrlSTM based on the X-ray crystal structure of 
CrlPM (4Q11) 
(A,B) Cartoon and surface representation of the CrlSTM model in which are shown the 
conserved residues of the Crl family members [16] forming three patches of surface-exposed 
residues. Zoomed views of residues belonging to patch 1 (C), patch 2 (D) and patch 3 (E). In 
patch 1, D36 establishes a salt bridge with R24 (distance between Asp36 Oδ1 and Arg24 Nε 
atoms of about 2.6 Å and 3.3 Å and between Asp36 Oδ2 and Arg24 Nν atoms of about 3.2 and 
2.7 in 4Q11 and CrlSTM model, respectively) and a hydrogen bond with Trp82 (distance 
between Asp36 Oδ2 and Trp82 Nε atoms of about 2.8 Å and 3.3 Å in 4Q11 and CrlSTM model, 
respectively). 
 
Figure 6. Structural and thermal stability characterization of the CrlSTM Asp36Ala and 
CrlSTM Arg51Ala variants 
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(A) Far-UV (200-260 nm) and near-UV (260-320 nm) CD spectra. (B) Fluorescence spectra 
recorded at an excitation wavelength of 280 nm (solid line) and 295 nm (dotted line). (C) 
DSC thermograms obtained at a scan rate of 200 °C/hour from 10 to 80 °C. The transition 
temperature and enthalpy for CrlSTM Asp36Ala were 60 ± 1 °C and ΔH = 16.5 ± 0.2 kcal mol-1, 
respectively, and for CrlSTM Arg51Ala were 59 ± 1 °C and ΔH = 31.6 ± 0.2 kcal mol-1. In all 
panels, wild-type CrlSTM is represented by solid lines, CrlSTM Asp36Ala by dotted lines and 
CrlSTM Arg51Ala by dashed lines. 
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